Search results
Results from the WOW.Com Content Network
The National Pollutant Release Inventory (NPRI), established in 1992, and launched in 1993, is the national pollutant release and transfer register of Canada. [ 1 ] [ 2 ] This list of pollutants contains releases from a facility to the air, water, and land along with disposals at, or from a facility. [ 3 ]
The drug or other substance has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use of the drug or other substance under medical supervision. The complete list of Schedule I substances is as follows. [1] The Administrative Controlled Substances Code Number for each substance is included.
The drug or other substance has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug or other substances may lead to severe psychological or physical dependence. The complete list of Schedule II substances is as follows.
This is the list of Schedule V controlled substances in the United States as defined by the Controlled Substances Act. [1] The following findings are required for substances to be placed in this schedule: [2] The drug or other substance has a low potential for abuse relative to the drugs or other substances in schedule IV.
Examples are mustard and nerve agents, and substances which are solely used as precursor chemicals in their manufacture. A few of these chemicals have very small-scale non-military applications; for example, minute quantities of nitrogen mustard are used to treat certain cancers. The Schedule 1 list is one of three lists.
The inventory was first proposed in a 1985 New York Times op-ed piece written by David Sarokin and Warren Muir, researchers for an environmental group, Inform, Inc. [2] Congress established TRI under Section 313 of the Emergency Planning and Community Right-to-Know Act of 1986 (EPCRA), and later expanded it in the Pollution Prevention Act of 1990 (PPA).
The drug or other substance has a potential for abuse less than the drugs or other substances in schedules I and II. The drug or other substance has a currently [1] accepted medical use in treatment in the United States. Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence.
The drug or other substance has a currently accepted medical use in treatment in the United States. Abuse of the drug or other substance may lead to limited physical dependence or psychological dependence relative to the drugs or other substances in schedule III. The complete list of Schedule IV substances is as follows.